(Q28376198)

2

0 references

L J Siever

3

0 references

C J Smith

4

0 references

P J Knott

5

0 references

K L Davis

Homovanillic acid measurement in clinical research: a review of methodology

6

0 references

language of work or name

English

0 references

publication date

1 May 1999

0 references

published in

Biological Psychiatry

0 references

volume

45

0 references

issue

9

0 references

page(s)

1143-50

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Assessment of the Central Dopaminergic Index of Plasma HVA in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Control of renal factors in plasma homovanillic acid measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Positive and negative symptoms in families with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Central dopamine turnover in schizophrenic syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Plasma catecholamine metabolites and treatment response at neuroleptic steady state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Deficit and nondeficit forms of schizophrenia: the concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Changes in Plasma Homovanillic Acid Concentrations in Schizophrenic Patients Following Neuroleptic Discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Symptoms and the genetics of schizophrenia: implications for diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

The search for a schizotype. Crossing the border again

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

A search for association between schizophrenia and dopamine-related alleles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

The positive and negative syndrome scale (PANSS) for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Diagnostic approaches to schizotypal personality disorder: a historical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Comparison of schizotypal relatives of schizophrenic versus affective probands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Personality disorders among the relatives of schizophrenia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

A critical review of genetic studies of schizophrenia. II. Molecular genetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Dopamine receptors and the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Plasma and CSF HVA before and after pharmacological treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Plasma homovanillic acid in schizotypal personality disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

CSF homovanillic acid in schizotypal personality disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

The search for a schizotypal personality: Historical origins and current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

A Structured Interview for the DSM-III Personality Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Serum homovanillic acid levels in schizophrenic patients and normal control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Genotypes, phenotypes, and the brain. A search for connections in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5

Implications of normal brain development for the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900262-5